T-cell therapy in the treatment of post-transplant lymphoproliferative disease
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://www.nature.com/articles/nrclinonc.2012.111.pdf
Reference84 articles.
1. Gottschalk, S., Rooney, C. M. & Heslop, H. E. Post-transplant lymphoproliferative disorders. Annu. Rev. Med. 56, 29–44 (2005).
2. Cohen, J. I. Epstein-Barr virus infection. N. Engl. J. Med. 343, 481–492 (2000).
3. Hislop, A. D., Taylor, G. S., Sauce, D. & Rickinson, A. B. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu. Rev. Immunol. 25, 587–617 (2007).
4. Khanna, R., Moss, D. & Gandhi, M. Technology insight: Applications of emerging immunotherapeutic strategies for Epstein-Barr virus-associated malignancies. Nat. Clin. Pract. Oncol. 2, 138–149 (2005).
5. Heslop, H. E. et al. Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients. Blood 115, 925–935 (2010).
Cited by 215 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Immune Cell Generation from Human-Induced Pluripotent Stem Cells: Current Status and Challenges;Advances in Pluripotent Stem Cells;2024-01-31
2. Virus-specific T-cells from third party or transplant donors for treatment of EBV lymphoproliferative diseases arising post hematopoietic cell or solid organ transplantation;Frontiers in Immunology;2024-01-11
3. Constitutive Interleukin-7 Cytokine Signaling Enhances the Persistence of Epstein–Barr Virus-Specific T-Cells;International Journal of Molecular Sciences;2023-10-31
4. Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study;Frontiers in Immunology;2023-10-30
5. Post‐Transplant Malignancy and Lymphoproliferative Diseases;Textbook of Transplantation and Mechanical Support for End‐Stage Heart and Lung Disease;2023-09-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3